Reported 2,073,970 shares, down 243,840 (10.5%) from the prior quarter.
Reported value -31.5%; share count -10.5% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 23490000 |
| 2022-03-31 | 11629000 |
| 2022-06-30 | 0 |
| 2024-03-31 | 114083000 |
| 2024-06-30 | 78126000 |
| 2024-09-30 | 34274000 |
| 2024-12-31 | 34172000 |
| 2025-03-31 | 16499000 |
| 2025-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2025 | Reduced | 0 | -373,874 (-100.0%) | 0 | $0 | 2025-08-14 | |
| Q1 2025 | Reduced | 373,874 | -571,934 (-60.5%) | 0.06% | $16,499,000 | 2025-05-13 | |
| Q4 2024 | Reduced | 945,808 | -123,930 (-11.6%) | 0.11% | $34,172,000 | 2025-02-14 | |
| Q3 2024 | Reduced | 1,069,738 | -1,004,232 (-48.4%) | 0.11% | $34,274,000 | 2024-11-14 | |
| Q2 2024 | Reduced | 2,073,970 | -243,840 (-10.5%) | 0.26% | $78,126,000 | 2024-08-14 | |
| Q1 2024 | New | 2,317,810 | +2,317,810 (0.0%) | 0.37% | $114,083,000 | 2024-05-09 | |
| Q2 2022 | Reduced | 0 | -206,054 (-100.0%) | 0 | $0 | 2022-08-12 | |
| Q1 2022 | Reduced | 206,054 | -172,953 (-45.6%) | 0.03% | $11,629,000 | 2022-05-13 | |
| Q4 2021 | Added | 379,007 | +25,091 (7.1%) | 0.05% | $23,490,000 | 2022-02-11 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
248 managers reported SPRINGWORKS THERAPEUTICS IN for Q2 2024.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| FMR LLC | Added | 11,112,391 | +44,365 | 0.03% | $418,603,769 | 20 qtrs |
| VANGUARD GROUP INC | Added | 6,544,413 | +15,088 | < 0.01% | $246,528,038 | 20 qtrs |
| BlackRock Inc | Added | 5,619,260 | +180,403 | < 0.01% | $211,677,525 | 20 qtrs |
| Deep Track Capital LP | Added | 3,700,000 | +220,147 | 4.16% | $139,379,000 | 8 qtrs |
| PRICE T ROWE ASSOCIATES INC MD | Reduced | 3,602,234 | -508,228 | 0.02% | $135,697,000 | 15 qtrs |
| Boxer Capital LLC | Unchanged | 3,421,541 | 0 | 6.79% | $128,889,449 | 20 qtrs |
| STATE STREET CORPORATION | Added | 3,086,845 | +125,221 | < 0.01% | $116,281,451 | 19 qtrs |
| MAVERICK CAPITAL LTD | Added | 2,600,524 | +691,894 | 1.86% | $97,961,739 | 4 qtrs |
| MARSHALL WACE LLP | Reduced | 2,333,117 | -633,505 | 0.12% | $87,888,517 | 6 qtrs |
| LORD ABBETT & CO LLC This report | Reduced | 2,073,970 | -243,840 | 0.26% | $78,126,000 | 2 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2024
- Filed
- August 14, 2024
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 2,040,492
- Shared
- 0
- None
- 33,478
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.